Phathom Pharmaceuticals, Inc. (PHAT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch PHAT
See up to 3 months of PHAT. The 7-day demo opens the 1M and 3M ranges and puts PHAT on your watchlist.
Start 7-day demoLatest PHAT insider trades
- Robert Charles Breedlove - OfficerOpen-market sale$7K
- Robert Charles Breedlove - OfficerOpen-market sale$6K
Sanjeev Narula
About Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. files with the SEC under CIK 0001783183 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
PHAT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 2 | 13,945 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PHAT insider transactions (Form 4)
5138 Form 4 filings on record, the earliest from Dec 16, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sanjeev Narula - Officer | Tax withholding / forfeiture | Common Stock | 13,485 | $6.78 | $91K | |
| Robert Charles Breedlove - Officer | Tax withholding / forfeiture | Common Stock | 460 | $9.05 | $4K | |
| Robert Charles Breedlove - Officer | Tax withholding / forfeiture | Common Stock | 1,555 | $11.04 | $17K | |
| Asit Parikh | Gift | Common Stock | 28,000 | $0.00 | - | |
| Asit Parikh | Gift | Common Stock | 28,000 | $0.00 | - | |
| Asit Parikh | Option exercise | Common Stock | 17,500 | $4.95 | $87K | |
| Asit Parikh | Derivative | Common Stock (Right to Buy) | 17,500 | $0.00 | - | |
| Asit Parikh | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
 James N. Topper | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
| Mark Stenhouse | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
| Heidi Fields | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
| Michael F. Cola | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
| Frank Karbe | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
| Theodore R. Schroeder | Grant or award | Common Stock | 24,122 footnote F1 | $0.00 | - | |
| ||||||
| Asit Parikh | Gift | Common Stock | 40,000 | $0.00 | - | |
| Asit Parikh | Gift | Common Stock | 40,000 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Tax withholding / forfeiture | Common Stock | 414 | $12.56 | $5K | |
| Robert Charles Breedlove - Officer | Grant or award | Common Stock | 13,000 footnote F1 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Grant or award | Common Stock | 2,790 footnote F2 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Tax withholding / forfeiture | Common Stock | 964 | $12.56 | $12K | |
| ||||||
| Anne Marie Cook - Officer | Grant or award | Common Stock | 3,461 footnote F1 | $0.00 | - | |
| Anne Marie Cook - Officer | Tax withholding / forfeiture | Common Stock | 1,535 | $12.82 | $20K | |
| ||||||
 Steven L. Basta - Officer | Grant or award | Common Stock | 12,362 footnote F1 | $0.00 | - | |
| Steven L. Basta - Officer | Tax withholding / forfeiture | Common Stock | 6,277 | $12.82 | $80K | |
| ||||||
| Asit Parikh | Gift | Common Stock | 80,500 | $0.00 | - | |
| Asit Parikh | Gift | Common Stock | 80,500 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Tax withholding / forfeiture | Common Stock | 776 | $13.61 | $11K | |
| Asit Parikh | Option exercise | Common Stock | 8,750 | $10.30 | $90K | |
| Asit Parikh | Option exercise | Common Stock (Right to Buy) | 8,750 | $0.00 | - | |
| Steven L. Basta - Officer | Grant or award | Common Stock | 251,034 | $0.00 | - | |
| Steven L. Basta - Officer | Grant or award | Stock Option (Right to Buy) | 226,156 | $0.00 | - | |
| Anne Marie Cook - Officer | Grant or award | Common Stock | 75,345 | $0.00 | - | |
| Anne Marie Cook - Officer | Grant or award | Stock Option (Right to Buy) | 67,878 | $0.00 | - | |
| Sanjeev Narula - Officer | Grant or award | Common Stock | 82,715 | $0.00 | - | |
| Sanjeev Narula - Officer | Grant or award | Stock Option (Right to Buy) | 42,848 | $0.00 | - | |
| Asit Parikh | Option exercise | Common Stock | 8,750 | $10.30 | $90K | |
| Asit Parikh | Option exercise | Common Stock (Right to Buy) | 8,750 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Tax withholding / forfeiture | Common Stock | 230 | $16.28 | $4K | |
| Anne Marie Cook - Officer | Grant or award | Common Stock | 17,370 footnote F1 | $0.00 | - | |
| Anne Marie Cook - Officer | Tax withholding / forfeiture | Common Stock | 7,703 | $15.36 | $118K | |
| ||||||
| Steven L. Basta - Officer | Grant or award | Common Stock | 62,038 footnote F1 | $0.00 | - | |
| Steven L. Basta - Officer | Tax withholding / forfeiture | Common Stock | 31,502 | $15.36 | $484K | |
| ||||||
| Steven L. Basta - Officer | Option exercise | Common Stock | 90,000 | $0.00 | - | |
| Steven L. Basta - Officer | Tax withholding / forfeiture | Common Stock | 48,375 | $15.62 | $756K | |
| Steven L. Basta - Officer | Option exercise | Performance Shares | 90,000 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Open-market sale | Common Stock | 524 | $13.51 | $7K | |
| Sanjeev Narula - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| Steven L. Basta - Officer | Option exercise | Common Stock | 90,000 | $0.00 | - | |
| Steven L. Basta - Officer | Tax withholding / forfeiture | Common Stock | 48,375 | $11.66 | $564K | |
| Steven L. Basta - Officer | Option exercise | Performance Shares | 90,000 | $0.00 | - | |
| Robert Charles Breedlove - Officer | Open-market sale | Common Stock | 461 | $12.09 | $6K | |
Item 8.01
Item 2.02, 9.01
Item 8.01
Item 5.07
PHAT insider trading FAQ
What is the latest insider trade for PHAT?
Phathom Pharmaceuticals, Inc. (PHAT) had 2 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for PHAT runs to 38 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PHAT stock?
No insider purchases of PHAT were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling PHAT stock?
No insider sales of PHAT were filed in the last 90 days. 5 sales are on record for this company.
Where can I see PHAT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PHAT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Sanjeev Narula view on EDGAR
- - Robert Charles Breedlove view on EDGAR
- - Robert Charles Breedlove view on EDGAR
- - Asit Parikh view on EDGAR
- - Asit Parikh view on EDGAR
- - James N. Topper view on EDGAR
- - Mark Stenhouse view on EDGAR
- - Heidi Fields view on EDGAR
- - Michael F. Cola view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PHAT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PHAT with a 7-day demo
- PHAT on your watchlist
- Every PHAT Form 4 filing on record
- Up to 3 months of PHAT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
